我們已在上線!
進一步了解
Celularity Inc
CELUW
CELUW
已下市
CELUW已於2026年7月17日下市。
關於: Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
員工: 115
新聞
正面
中性
負面
市場情緒
3個月
正面
0%
中性
0%
負面
0%
我們尚未收到任何關於CELUW的最新新聞文章。
價格圖表採用Lightweight Charts™實作